Kodiak Sciences Inc.
Kodiak Sciences Inc. (KOD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KOD · as of Jun 8, 2026
Key Statistics
Explore Kodiak Sciences Inc. Data
kod stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 18 · Buy rate: 72.2%
The KOD analyst consensus is Buy, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month price target is $63.75, representing +115.30% upside from the current price of $29.61.
Competitors & Peers
kod competitorsKOD
ANAB
BBOT
EYPT
NRIX
OCSStock Performance
Full HistoryAbout Kodiak Sciences Inc.
Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting th…
what is kodiak sciences inc. · kod stock overview · kodiak sciences inc. company profile · who is kodiak sciences inc. ceo · kod NASDAQ · kodiak sciences inc. headquarters · kodiak sciences inc. business segments
About Stock Overview & Key Data
Kodiak Sciences Inc. (KOD) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 4, 2018. As of the latest trading session, KOD stock price is $29.61, with a market capitalization of $1.6B. The stock has returned +613.49% over the past 12 months and +5.90% year-to-date.
According to 18 Wall Street analysts, the consensus rating for Kodiak Sciences Inc. stock is Buy, with an average 12-month price target of $63.75. In fiscal year 2025, Kodiak Sciences Inc. reported revenue of — and net income of -$230.0M. For detailed data — including Kodiak Sciences Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kodiak Sciences Inc. (KOD) stock price is $29.61. The stock is traded on NASDAQ under the ticker symbol KOD. The 52-week range is $3.43 – $47.84.